Possible link between SSRIs and breast and ovarian cancer
Friday 6 May 2011
A meta-analysis shows a possible link between use of selective serotonin reuptake inhibitors (SSRIs) and the risk of breast and ovarian cancer. The meta-analysis looked at 35 preclinical and 26 epidemiologic studies. However, experts cautioned female SSRI users that the study has limitations. Read more on Medscape
European Oncology Nursing SocietyAvenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu